分子癌症研究 SCIE

期刊简介预计审稿时间： 偏慢,4-8周

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.

《分子癌症研究》发表的文章描述了该领域广泛关注的新型基础癌症研究发现。研究必须具有显著意义，该期刊优先考虑在分子和细胞水平上进行的分析，这些分析揭示了与癌症风险、发展和/或进展相关的途径和过程的新机制见解。重点领域包括所有与癌症相关的途径（包括细胞周期调控；细胞死亡；染色质调控；DNA 损伤和修复；基因和 RNA 调控；基因组学；致癌基因和肿瘤抑制因子；信号转导；以及肿瘤微环境），以及描述支持癌症表型的新分子机制和相互作用的研究。为了获得充分考虑，主要研究提交必须提供对现有途径功能的重大新见解或解决与癌症相关的生物学问题相关的新假设。

《Molecular Cancer Research》(分子癌症研究)编辑部通讯方式为AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。